Back
Pacira BioSciences Vs. Arbutus Biopharma Industry Stock Comparison
Buy
57
PCRX
Pacira BioSciences
Last Price:
30.79
Seasonality Move:
7.59%
Buy
60
ABUS
Arbutus Biopharma
Last Price:
2.99
Seasonality Move:
14.85%
Buy
57
Pacira BioSciences (PCRX)
is a Buy
Is Pacira BioSciences a Buy, Sell or Hold?
- The current Pacira BioSciences [PCRX] share price is $30.82. The Score for PCRX is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- PCRX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
60
Arbutus Biopharma (ABUS)
is a Buy
Is Arbutus Biopharma a Buy, Sell or Hold?
- The current Arbutus Biopharma [ABUS] share price is $2.98. The Score for ABUS is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- ABUS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PCRX Stock Price Chart
What is Pacira BioSciences's stock price today?
-
The Pacira BioSciences share price today is $30.82
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PCRX is experiencing selling pressure, which indicates risk of future bearish movement.
ABUS Stock Price Chart
What is Arbutus Biopharma's stock price today?
-
The Arbutus Biopharma share price today is $2.98
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ABUS is experiencing buying pressure, which is a positive indicator for future bullish movement.
PCRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.86 | Buy |
| Relative Strength Index (14 RSI): | 62.81 | Buy |
| Chaikin Money Flow: | -360300 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (25.83 - 29.57) | Buy |
| Bollinger Bands (100): | (27.58 - 32.1) | Buy |
ABUS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.04 | Buy |
| Relative Strength Index (14 RSI): | 61.5 | Buy |
| Chaikin Money Flow: | 372698 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.71 - 2.89) | Buy |
| Bollinger Bands (100): | (2.46 - 2.88) | Buy |
PCRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 30.32 | Buy |
| 20-day SMA: | 28 | Buy |
| 50-day SMA: | 28.39 | Buy |
| 200-day SMA: | 30.72 | Buy |
| 8-day EMA: | 30.06 | Buy |
| 20-day EMA: | 28.85 | Buy |
| 50-day EMA: | 28.63 | Buy |
| 200-day EMA: | 31.56 | Sell |
ABUS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.89 | Buy |
| 20-day SMA: | 2.8 | Buy |
| 50-day SMA: | 2.76 | Buy |
| 200-day SMA: | 2.32 | Buy |
| 8-day EMA: | 2.88 | Buy |
| 20-day EMA: | 2.83 | Buy |
| 50-day EMA: | 2.77 | Buy |
| 200-day EMA: | 2.52 | Buy |
Pacira BioSciences Earnings Growth & PCRX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.10 per share, an increase next quarter of $0.25 per share, a decrease this year of $0.14 per share, and an increase next year of $0.80 per share.
Arbutus Biopharma Earnings Growth & ABUS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, an increase next quarter of $0.01 per share, an increase this year of $0.07 per share, and a decrease next year of $0.00 per share.
Pacira BioSciences Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Arbutus Biopharma Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||